Re-Envisioning Anti-Apicomplexan Parasite Drug Discovery Approaches
Parasites of the phylum Apicomplexa impact humans in nearly all parts of the world, causing diseases including to toxoplasmosis, cryptosporidiosis, babesiosis, and malaria. Apicomplexan parasites have complex life cycles comprised of one or more stages characterized by rapid replication and biomass...
Main Authors: | Gabriel W. Rangel, Manuel Llinás |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2021.691121/full |
Similar Items
-
New approaches in antimalarial drug discovery and development: a review
by: Anna Caroline C Aguiar, et al.
Published: (2012-11-01) -
Editorial: From Apicomplexan Genes to Drug Discovery
by: Gerhard Wunderlich, et al.
Published: (2021-11-01) -
Sentinel network for monitoring in vitro susceptibility of Plasmodium falciparum to antimalarial drugs in Colombia: a proof of concept
by: Samanda L Aponte, et al.
Published: (2011-08-01) -
Incidence of malarial infection and response to antimalarial drugs at Districts Lower Dir and Swat of Khyber Pakhtunkhwa, Pakistan
by: Nasib Zaman, et al.
Published: (2022-12-01) -
The role of private drug vendors as malaria treatment providers in selected malaria endemic areas of Sri Lanka
by: R.S. Rajakaruna, M. Weerasinghe, M. Alifrangis, P.H. Amerasinghe & F. Konradsen
Published: (2006-06-01)